Free Trial
OTCMKTS:LEAS

Anew Medical (LEAS) Stock Price, News & Analysis

Anew Medical logo
$0.0003 0.00 (0.00%)
As of 06/21/2024

About Anew Medical Stock (OTCMKTS:LEAS)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0098
Volume
N/A
Average Volume
4.57 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ANEW MEDICAL, INC. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.

Receive LEAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anew Medical and its competitors with MarketBeat's FREE daily newsletter.

LEAS Stock News Headlines

Adia Nutrition Secures Lease for First Clinic in Winter Park, Florida
"I'm risking my reputation on this"
What the headlines won't tell you: Smart money was positioned before both events. They didn't react to news—they anticipated it. How? They follow patterns. Market cycles. Institutional flows. The same patterns we document in Crypto Revolution and the next pattern is forming now.
Investors acquire Lake Oswego medical offices
KLTO Klotho Neurosciences, Inc.
See More Headlines

LEAS Stock Analysis - Frequently Asked Questions

Anew Medical's stock was trading at $0.0003 on January 1st, 2025. Since then, LEAS stock has increased by 0.0% and is now trading at $0.0003.
View the best growth stocks for 2025 here
.

Shares of LEAS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Anew Medical investors own include Verb Technology (VERB), Aethlon Medical (AEMD), Avinger (AVGR), BIOLASE (BIOL), Creative Medical Technology (CELZ) and Castor Maritime (CTRM).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Rental & Leasing Services
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LEAS
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:LEAS) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners